- Home
- ADAG vs HGBL Comparison
ADAG vs HGBL Comparison
Compare ADAG & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- HGBL
- Stock Information
- Founded
- ADAG 2011
- HGBL 1937
- Country
- ADAG China
- HGBL United States
- Employees
- ADAG N/A
- HGBL N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- HGBL Business Services
- Sector
- ADAG Health Care
- HGBL Consumer Discretionary
- Exchange
- ADAG Nasdaq
- HGBL Nasdaq
- Market Cap
- ADAG 81.9M
- HGBL 72.3M
- IPO Year
- ADAG 2021
- HGBL N/A
- Fundamental
- Price
- ADAG $1.60
- HGBL $2.00
- Analyst Decision
- ADAG Strong Buy
- HGBL Strong Buy
- Analyst Count
- ADAG 1
- HGBL 1
- Target Price
- ADAG $8.00
- HGBL $4.00
- AVG Volume (30 Days)
- ADAG 15.4K
- HGBL 60.7K
- Earning Date
- ADAG 03-24-2025
- HGBL 05-08-2025
- Dividend Yield
- ADAG N/A
- HGBL N/A
- EPS Growth
- ADAG N/A
- HGBL N/A
- EPS
- ADAG N/A
- HGBL 0.14
- Revenue
- ADAG $103,204.00
- HGBL $45,361,000.00
- Revenue This Year
- ADAG $6,488.89
- HGBL $10.82
- Revenue Next Year
- ADAG $57.50
- HGBL $15.17
- P/E Ratio
- ADAG N/A
- HGBL $14.29
- Revenue Growth
- ADAG N/A
- HGBL N/A
- 52 Week Low
- ADAG $1.33
- HGBL $1.52
- 52 Week High
- ADAG $3.58
- HGBL $2.74
- Technical
- Relative Strength Index (RSI)
- ADAG 51.88
- HGBL 43.72
- Support Level
- ADAG $1.51
- HGBL $1.96
- Resistance Level
- ADAG $1.74
- HGBL $2.07
- Average True Range (ATR)
- ADAG 0.10
- HGBL 0.08
- MACD
- ADAG 0.03
- HGBL 0.00
- Stochastic Oscillator
- ADAG 61.84
- HGBL 21.05
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
About HGBL Heritage Global Inc.
Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.